Skip to main content

Pinealon vs Semax

Both Pinealon and Semax are used for cognitive. Here's how their evidence, dosing, and regulatory status actually compare.

Pinealon

Evidence C

Pinealon (EDR)

A short tripeptide developed in Russia for cognitive aging and oxidative stress. Limited Western clinical evidence.

View full Pinealon profile →

Semax

Evidence B

Semax (MEHFPGP)

A synthetic ACTH fragment that increases BDNF levels and enhances focus, memory, and mental clarity. Delivered intranasally for rapid cognitive effects.

View full Semax profile →

Side-by-Side

AttributePinealonSemax
Evidence GradeCB
FDA StatusNot FDA-approved — Russian-origin research peptideNot FDA-approved in US — approved in Russia for stroke and cognitive disorders
Typical Dose5–10 mg daily for 10–20 days (subcutaneous, cycled)200–600 mcg intranasal, morning
Clinics Indexed989
Categoriescognitive, longevitycognitive, neuroprotection

Key reported benefits — Pinealon

  • Cognitive function (preclinical)
  • Reduced oxidative damage
  • Sleep/circadian effects

Key reported benefits — Semax

  • BDNF increase
  • Enhanced focus
  • Memory improvement
  • Neuroprotection

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons